Bulk and single-cell RNA sequencing data identified HMGB3 of chromatin regulators as a breast cancer biomarker associated with the cell cycle - Top-Institutions - MDSpire

Bulk and single-cell RNA sequencing data identified HMGB3 of chromatin regulators as a breast cancer biomarker associated with the cell cycle

  • By

  • Huan Wang

  • Luhui Li

  • Dingyuan Tu

  • Ping Shen

  • Zheyao Song

  • Mengjiao An

  • Xudong Li

  • Qi Ji

  • Peng Chen

  • Rongjun Cui

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    MD Anderson’s Institute for Data Science in Oncology (IDSO)
    MD Anderson’s Institute for Data Science in Oncology (IDSO)

    Houston, Texas

    Key Differentiators

    • Oncology

  • #3

    Department of Breast Medical Oncology
    Department of Breast Medical Oncology

    Houston, Texas

    Key Differentiators

    • Oncology

  • #4

    Chinese Glioma Genome Atlas
    Chinese Glioma Genome Atlas

    N/A, N/A

    Key Differentiators

    • Genomics

  • #5

    The Cancer Genome Atlas
    The Cancer Genome Atlas

    N/A, N/A

    Key Differentiators

    • Genomics

Original Source(s)

Bulk and single-cell RNA sequencing data identified HMGB3 of chromatin regulators as a breast cancer biomarker associated with the cell cycle

  • by Huan Wang, Luhui Li, Dingyuan Tu, Ping Shen, Zheyao Song, Mengjiao An, Xudong Li, Qi Ji, Peng Chen, Rongjun Cui

  • June 11, 2026

Related Content

Case Report: A rare triad of neoplasms: navigating synchronous accessory breast cancer, papillary thyroid carcinoma, and inflammatory nasal papilloma

Tertiary lymphoid structures in breast cancer: formation, immune functions and clinical implications

Global research trends of TCM-based nonpharmacologic interventions in breast cancer supportive care: a bibliometric analysis (2000–2025)